SC 13G/A
Amended Statement of Ownership
PALVELLA THERAPEUTICS, INC. Filed Acc 0000902664-24-006519
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-10-28 SCHEDULE 13G/A · Jennison Associates LLC 7.7%
- 2026-08-14 SCHEDULE 13G/A · First Light Asset Management, LLC 5.34%
- 2026-08-14 SCHEDULE 13G/A · BVF PARTNERS L P/IL 4.7%
- 2026-08-10 SCHEDULE 13G · PRUDENTIAL FINANCIAL INC 6.7%
- 2026-08-03 SCHEDULE 13G · Jennison Associates LLC 6.7%
- 2026-07-29 SCHEDULE 13G · BlackRock, Inc. 5.7%
- 2026-02-17 SCHEDULE 13G · First Light Asset Management, LLC 7.49%
- 2026-02-17 SCHEDULE 13G/A · BVF PARTNERS L P/IL 7.1%
- 2026-02-13 SCHEDULE 13G/A · Frazier Life Sciences Public Fund, L.P. 6.0%
- 2025-11-14 SCHEDULE 13G/A · BVF PARTNERS L P/IL 9.99%
- 2025-11-13 SCHEDULE 13G/A · SUVRETTA CAPITAL MANAGEMENT, LLC 7.4%
- 2025-08-14 SCHEDULE 13G/A · Samsara BioCapital, L.P. 3.1%
- 2024-12-20 SCHEDULE 13D · Kaupinen Wes 14.6%
- 2018-02-12 SC 13G/A · Tekla Capital Management LLC 4.4%
Loading p24-3210sc13ga.htm…